Oxford Immunotec Global PLC

(NASDAQ:OXFD)

Latest On Oxford Immunotec Global PLC (OXFD):

Date/Time Type Description Signal Details
2021-02-10 16:32 ESTNewsOxford signs MOU with Green Cross Medical for T-SPOT Discovery SARS-CoV-2 kitN/A
2021-02-04 19:16 ESTNewsOxford Immunotec updates T-SPOT COVID-19 test kit with new panelN/A
2021-01-28 11:31 ESTNewsOxford Immunotec: PerkinElmer Offer Provides A Fair Exit For ShareholdersN/A
2021-01-13 17:17 ESTNewsOxford Immunotec's COVID-19 test to be used Valneva’s COVID-19 vaccine candidate trialN/A
2021-01-08 04:18 ESTAnalyst RatingThe Analyst Target Price has decreased from $23 to $22.5.Neutral
2021-01-07 15:18 ESTNewsPerkinElmer to acquire Oxford Immunotec for $591MN/A
2020-12-21 04:53 ESTAnalyst RatingThe Analyst Target Price has increased from $19.25 to $23.Buy
2020-12-18 04:31 ESTAnalyst RatingThe Analyst Target Price has increased from $18.25 to $19.25.Buy
2020-12-17 22:06 ESTNewsOxford Immunotec to ramp up share buybacksN/A
2020-12-10 16:33 ESTNewsOxford Immunotec's reagent for TB diagnosis, OK'd in South KoreaN/A
2020-12-03 05:08 ESTNewsOxford Immunotec Global inks distribution pact with RIKEN GenesisN/A
2020-11-26 21:08 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 21:52 ESTNewsOxford T-Spot test shows key role of T cells in COVID-19 immunityN/A
2020-11-09 16:25 ESTNewsOxford Immunotec Global PLC 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-08 00:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:45 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 00:28 ESTFinancialsCompany financials have been released.Neutral
2020-11-04 08:36 ESTNewsOxford Immunotec Global EPS beats by $0.04, beats on revenueN/A
2020-11-04 08:36 ESTNewsOxford Immunotec Global PLC (OXFD) CEO Peter Wrighton-Smith on Q3 2020 Results - Quick Version Earnings Call TranscriptN/A
2020-11-04 08:35 ESTNewsOxford Immunotec Global PLC (OXFD) CEO Peter Wrighton-Smith on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-04 08:26 ESTEarnings EstimateAn EPS average of -$0.14 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-04 08:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.33 to $18.25.Neutral
2020-10-23 05:09 ESTNewsOxford Immunotec selected for T cell testing for SARS-CoV-2 by the U.K. Govt bodyN/A
2020-09-30 13:26 ESTNewsFDA OKs expanded use of Oxford Immunotec TB testN/A
2020-09-26 13:40 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:46 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 05:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.5 to $18.33.Neutral
2020-08-09 20:28 ESTNewsOxford Immunotec Global PLC (OXFD) CEO Peter Wrighton-Smith on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-09 01:26 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 01:25 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:30 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:38 ESTNewsOxford Immunotec Global EPS misses by $0.07, revenue in-lineN/A
2020-08-04 19:37 ESTNewsOxford Immunotec Global PLC 2020 Q2 - Results - Earnings Call PresentationN/A
2020-07-31 01:57 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 17:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:22 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 18:02 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 09:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 17:24 ESTFinancialsCompany financials have been released.Neutral
2020-06-26 16:15 ESTInsider TradeAndrew Scott Walton has directly acquired 4,081 shares and currently holds 4,081 shares.Buy
2020-06-26 16:15 ESTInsider TradeJAMES R TOBIN has directly acquired 4,081 shares and currently holds 4,081 shares.Buy
2020-06-26 16:15 ESTInsider TradeRICHARD A SANDBERG has directly acquired 4,081 shares and currently holds 4,081 shares.Buy
2020-06-26 16:15 ESTInsider TradeHERM ROSENMAN has directly acquired 4,081 shares and currently holds 4,081 shares.Buy
2020-06-26 16:15 ESTInsider TradePATRICIA RANDALL has directly acquired 4,081 shares and currently holds 27,805 shares.Buy
2020-06-26 16:15 ESTInsider TradeMark R. Klausner has directly acquired 4,081 shares and currently holds 4,081 shares.Buy
2020-06-26 16:15 ESTInsider TradePATRICK J BALTHROP has directly acquired 4,081 shares and currently holds 4,081 shares.Buy
2020-06-26 16:15 ESTInsider TradeRONALD ASBURY ANDREWS has directly acquired 4,081 shares and currently holds 4,081 shares.Buy

About Oxford Immunotec Global PLC (OXFD):

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

OXFD Quotes by TradingView

See Advanced Chart

General

  • Name Oxford Immunotec Global PLC
  • Symbol OXFD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 273
  • Fiscal Year EndDecember
  • IPO Date2013-11-22
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.oxfordimmunotec.com
View More

Valuation

  • Trailing PE 11.75
  • Price/Sales (Trailing 12 Mt.) 10.01
  • Price/Book (Most Recent Quarter) 2.94
  • Enterprise Value Revenue 7.16
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.05
  • Profit Margin -31%
  • Operating Margin -31%
  • Return on Assets -5%
  • Return on Equity -8%
  • Revenue 57.3 million
  • Earnings Per Share $5.18
  • Revenue Per Share $2.2
  • Gross Profit 54.42 million
  • Quarterly Earnings Growth -8.4%
View More

Highlights

  • Market Capitalization 562.46 million
  • EBITDA -10253000
  • Analyst Target Price $22.5
  • Book Value Per Share $7.37
View More

Share Statistics

  • Shares Outstanding 25.58 million
  • Shares Float 19.21 million
  • % Held by Insiders 189%
  • % Held by Institutions 95.72%
  • Shares Short 136459
  • Shares Short Prior Month 153441
  • Short Ratio 0.14
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.38
  • 52 Week High $23.11
  • 52 Week Low $8.81
  • 50 Day Moving Average 21.94
  • 200 Day Moving Average 16.46
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Oxford Immunotec Global PLC (OXFD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Oxford Immunotec Global PLC (OXFD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-03$19.44 million-$0.01-$0.0578.17%
2020-06-302020-08-04$N/A-$0.37-$0.30-21.39%
2020-03-312020-05-05$13.91 million-$0.23-$0.15-49.06%
2019-12-312020-03-02$18.11 million-$0.06-$0.0935.9%
2019-09-302019-11-05$21.22 million$0.03-$0.03219.52%
2019-06-302019-08-06$19.59 million$0.02-$0.05140.57%
2019-03-312019-05-09$14.79 million-$0.06-$0.2069.79%
2018-12-312019-03-11$15.37 million$5.23-$0.153547.59%
2018-09-302018-11-09$16.05 million-$0.13-$0.10-25%
2018-06-302018-07-31$6.97 million-$0.25-$0.250.52%
2018-03-312018-05-01$21.37 million-$0.40-$0.4511.84%
2017-12-312018-02-27$25.03 million$0.33-$0.36192.08%
2017-09-302017-10-31$30.43 million-$0.70-$0.26-169.96%
2017-06-302017-08-01$26.12 million-$0.74-$0.32-133.29%
2017-03-312017-05-02$21.51 million-$0.36-$0.36-1.12%
2016-12-312017-02-28$23.71 million-$0.22-$0.3943.46%
2016-09-302016-11-01$26.11 million-$0.18-$0.3345.39%
2016-06-302016-08-02$19.15 million-$0.29-$0.3414.96%
2016-03-312016-05-03$17.11 million-$0.32-$0.346.41%
2015-12-312016-03-01$16.79 million-$0.29-$0.28-4.02%
2015-09-302015-11-03$17.94 million-$0.20-$0.2520%
2015-06-302015-08-04$14.25 million-$0.33-$0.342.94%
2015-03-312015-05-05$13.8 million-$0.31-$0.3716.22%
2014-12-312015-03-03$12.12 million-$0.39-$0.439.3%
2014-09-302014-11-04$13.33 million-$0.35-$0.375.41%
2014-06-302014-08-05$11.79 million-$0.36-$0.20-80%
2014-03-312014-05-06$12.27 million-$0.18-$0.180%
2013-12-312014-03-04$10.23 million-$0.29-$0.24-20.83%
2013-09-302013-11-27$10.73 million-$0.19

Oxford Immunotec Global PLC (OXFD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Oxford Immunotec Global PLC (OXFD) Chart:

Oxford Immunotec Global PLC (OXFD) News:

Below you will find a list of latest news for Oxford Immunotec Global PLC (OXFD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Oxford Immunotec Global PLC (OXFD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Oxford Immunotec Global PLC (OXFD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013988/0001437749-20-013988-index.htm
2020-03-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000090266420001679/0000902664-20-001679-index.htm
2019-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000091420819000078/0000914208-19-000078-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000091420820000141/0000914208-20-000141-index.htm
2020-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000091420820000345/0000914208-20-000345-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000108514619000742/0001085146-19-000742-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000108514620000792/0001085146-20-000792-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000110465920021825/0001104659-20-021825-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000114420419008065/0001144204-19-008065-index.htm
2020-04-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000115752320000594/0001157523-20-000594-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000117266119000628/0001172661-19-000628-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000117266120000503/0001172661-20-000503-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000119380519000188/0001193805-19-000188-index.htm
2019-08-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000131924419000072/0001319244-19-000072-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000131924420000051/0001319244-20-000051-index.htm
2018-10-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000138713118005632/0001387131-18-005632-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000138713119001260/0001387131-19-001260-index.htm
2019-03-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000138713119001803/0001387131-19-001803-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000138713119009474/0001387131-19-009474-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000138713120001826/0001387131-20-001826-index.htm
2020-05-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000138713120005231/0001387131-20-005231-index.htm
2018-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774918014062/0001437749-18-014062-index.htm
2018-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774918014436/0001437749-18-014436-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774918016812/0001437749-18-016812-index.htm
2018-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774918017254/0001437749-18-017254-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774918017408/0001437749-18-017408-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774918017553/0001437749-18-017553-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774918017909/0001437749-18-017909-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774918018201/0001437749-18-018201-index.htm
2018-11-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774918019297/0001437749-18-019297-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774918020161/0001437749-18-020161-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774918020171/0001437749-18-020171-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774918020173/0001437749-18-020173-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000189/0001437749-19-000189-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000190/0001437749-19-000190-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000379/0001437749-19-000379-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000481/0001437749-19-000481-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000548/0001437749-19-000548-index.htm
2019-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000644/0001437749-19-000644-index.htm
2019-01-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000741/0001437749-19-000741-index.htm
2019-01-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919000742/0001437749-19-000742-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919001701/0001437749-19-001701-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919002954/0001437749-19-002954-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919004216/0001437749-19-004216-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919004471/0001437749-19-004471-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919004556/0001437749-19-004556-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919004557/0001437749-19-004557-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919004559/0001437749-19-004559-index.htm
2019-03-18NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1586049/000143774919005188/0001437749-19-005188-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919005425/0001437749-19-005425-index.htm
2019-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919005426/0001437749-19-005426-index.htm
2019-03-26PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919005707/0001437749-19-005707-index.htm
2019-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1586049/000143774919005832/0001437749-19-005832-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919006476/0001437749-19-006476-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919006477/0001437749-19-006477-index.htm
2019-04-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919006887/0001437749-19-006887-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919006888/0001437749-19-006888-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919008331/0001437749-19-008331-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919008716/0001437749-19-008716-index.htm
2019-05-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1586049/000143774919008717/0001437749-19-008717-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919009165/0001437749-19-009165-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774919009302/0001437749-19-009302-index.htm
2019-06-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1586049/000143774919011983/0001437749-19-011983-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012078/0001437749-19-012078-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012282/0001437749-19-012282-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012283/0001437749-19-012283-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012284/0001437749-19-012284-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012285/0001437749-19-012285-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012286/0001437749-19-012286-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012287/0001437749-19-012287-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012288/0001437749-19-012288-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012289/0001437749-19-012289-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919012475/0001437749-19-012475-index.htm
2019-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919014155/0001437749-19-014155-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919015473/0001437749-19-015473-index.htm
2019-08-054/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919015509/0001437749-19-015509-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919015523/0001437749-19-015523-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774919015566/0001437749-19-015566-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919017192/0001437749-19-017192-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919018532/0001437749-19-018532-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919019043/0001437749-19-019043-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919019606/0001437749-19-019606-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919021507/0001437749-19-021507-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774919021535/0001437749-19-021535-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919021587/0001437749-19-021587-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774919023280/0001437749-19-023280-index.htm
2019-11-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919023281/0001437749-19-023281-index.htm
2019-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774919023282/0001437749-19-023282-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920004045/0001437749-20-004045-index.htm
2020-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1586049/000143774920004480/0001437749-20-004480-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920005157/0001437749-20-005157-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920005158/0001437749-20-005158-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920005159/0001437749-20-005159-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920005160/0001437749-20-005160-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920007033/0001437749-20-007033-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920007287/0001437749-20-007287-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920008125/0001437749-20-008125-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920008840/0001437749-20-008840-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920009351/0001437749-20-009351-index.htm
2020-05-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774920009388/0001437749-20-009388-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920010441/0001437749-20-010441-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920011569/0001437749-20-011569-index.htm
2020-06-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1586049/000143774920012198/0001437749-20-012198-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013861/0001437749-20-013861-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013979/0001437749-20-013979-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013980/0001437749-20-013980-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013982/0001437749-20-013982-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013984/0001437749-20-013984-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013985/0001437749-20-013985-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013986/0001437749-20-013986-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013987/0001437749-20-013987-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920013988/0001437749-20-013988-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920016379/0001437749-20-016379-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774920016413/0001437749-20-016413-index.htm
2020-09-024/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1586049/000143774920019222/0001437749-20-019222-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1586049/000143774920022301/0001437749-20-022301-index.htm
2020-11-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1586049/000143774920022320/0001437749-20-022320-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000145307219000040/0001453072-19-000040-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1586049/000145307220000025/0001453072-20-000025-index.htm
2018-08-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1586049/999999999718007340/9999999997-18-007340-index.htm
2018-09-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1586049/999999999718007935/9999999997-18-007935-index.htm
2018-10-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1586049/999999999718008637/9999999997-18-008637-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1586049/999999999718009563/9999999997-18-009563-index.htm
2019-03-07CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1586049/999999999719000820/9999999997-19-000820-index.htm
2019-05-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1586049/999999999719004517/9999999997-19-004517-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1586049/999999999720000545/9999999997-20-000545-index.htm
2020-02-20SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1586049/999999999720000829/9999999997-20-000829-index.htm

Oxford Immunotec Global PLC (OXFD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oxford Immunotec Global PLC (OXFD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 189%
Institutional Ownership: 9572%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-01RICHARD A SANDBERGDirectorSell3,000.0019.9059,702.700.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919015473/0001437749-19-015473-index.htm
2019-11-01RICHARD A SANDBERGDirectorSell3,000.0015.6046,800.000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919021587/0001437749-19-021587-index.htm
2019-11-18Janet Louise KiddGeneral CounselBuy11,207.0011,207.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919023282/0001437749-19-023282-index.htm
2018-08-01RICHARD A SANDBERGDirectorSell3,000.0013.1539,450.0012,000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918014436/0001437749-18-014436-index.htm
2019-11-01RICHARD A SANDBERGDirectorBuy1,650.000.09148.501,650.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919021587/0001437749-19-021587-index.htm
2020-03-12PATRICIA RANDALLDirectorBuy15,074.000.091,356.6623,724.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920005159/0001437749-20-005159-index.htm
2019-04-08Matthew T E McLaughlinChief Financial OfficerBuy26,612.0026,612.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919006888/0001437749-19-006888-index.htm
2019-03-04Elizabeth M KeileySVP & General CounselSell4,100.0017.0069,711.8926,928.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919004216/0001437749-19-004216-index.htm
2020-06-24PATRICIA RANDALLDirectorBuy4,081.0027,805.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013985/0001437749-20-013985-index.htm
2019-10-01Peter Wrighton-SmithChief Executive OfficerSell30,000.0016.21486,402.00294,538.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919019606/0001437749-19-019606-index.htm
2019-11-01RICHARD A SANDBERGDirectorBuy1,350.008.6511,677.503,000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919021587/0001437749-19-021587-index.htm
2019-05-01RICHARD A SANDBERGDirectorSell3,000.0016.0548,155.103,000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919008716/0001437749-19-008716-index.htm
2019-09-24Peter Wrighton-SmithChief Executive OfficerSell80,000.0017.011,361,096.00324,538.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919019043/0001437749-19-019043-index.htm
2020-03-11Peter Wrighton-SmithChief Executive OfficerBuy62,087.00356,625.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920005157/0001437749-20-005157-index.htm
2020-05-08Peter Wrighton-SmithChief Executive OfficerBuy2,075.0010.7522,306.25358,700.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920010441/0001437749-20-010441-index.htm
2020-05-11Peter Wrighton-SmithChief Executive OfficerBuy26,000.0011.45297,700.00384,700.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920010441/0001437749-20-010441-index.htm
2020-05-20PATRICK J BALTHROPDirectorBuy4,000.0012.4849,920.004,000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920011569/0001437749-20-011569-index.htm
2020-05-12Peter Wrighton-SmithChief Executive OfficerBuy15,525.0011.56179,469.00400,225.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920010441/0001437749-20-010441-index.htm
2019-09-23Peter Wrighton-SmithChief Executive OfficerSell20,000.0014.92298,366.00404,538.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919019043/0001437749-19-019043-index.htm
2020-06-24Andrew Scott WaltonDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013979/0001437749-20-013979-index.htm
2020-06-24HERM ROSENMANDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013984/0001437749-20-013984-index.htm
2020-06-24JAMES R TOBINDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013980/0001437749-20-013980-index.htm
2020-06-24Mark R. KlausnerDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013986/0001437749-20-013986-index.htm
2020-06-24PATRICK J BALTHROPDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013987/0001437749-20-013987-index.htm
2020-06-24RICHARD A SANDBERGDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013982/0001437749-20-013982-index.htm
2020-06-24RONALD ASBURY ANDREWSDirectorBuy4,081.004,081.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920013988/0001437749-20-013988-index.htm
2019-02-19Peter Wrighton-SmithChief Executive OfficerSell10,000.0016.99169,934.00413,469.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919002954/0001437749-19-002954-index.htm
2019-01-10Peter Wrighton-SmithChief Executive OfficerSell10,000.0014.91149,073.00423,469.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919000742/0001437749-19-000742-index.htm
2019-08-16Peter Wrighton-SmithChief Executive OfficerSell10,000.0013.86138,647.00424,538.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919017192/0001437749-19-017192-index.htm
2018-10-02Peter Wrighton-SmithChief Executive OfficerSell10,000.0016.93169,260.00433,469.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918017909/0001437749-18-017909-index.htm
2019-04-01Peter Wrighton-SmithChief Executive OfficerSell600.0017.2110,325.76434,538.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919006477/0001437749-19-006477-index.htm
2019-04-01Peter Wrighton-SmithChief Executive OfficerSell10,000.0016.64166,446.00435,138.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919006477/0001437749-19-006477-index.htm
2018-10-01Peter Wrighton-SmithChief Executive OfficerSell10,000.0016.50165,000.00443,469.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918017909/0001437749-18-017909-index.htm
2019-04-01Peter Wrighton-SmithChief Executive OfficerBuy31,669.00445,138.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919006477/0001437749-19-006477-index.htm
2018-09-25Peter Wrighton-SmithChief Executive OfficerSell46,100.0018.92872,064.48453,469.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918017553/0001437749-18-017553-index.htm
2018-09-07Peter Wrighton-SmithChief Executive OfficerSell40,000.0014.95598,000.00485,296.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918016812/0001437749-18-016812-index.htm
2018-09-25Peter Wrighton-SmithChief Executive OfficerSell40,000.0017.84713,704.00499,569.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918017553/0001437749-18-017553-index.htm
2018-09-07Peter Wrighton-SmithChief Executive OfficerBuy40,000.000.8132,400.00525,296.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918016812/0001437749-18-016812-index.htm
2018-09-25Peter Wrighton-SmithChief Executive OfficerBuy54,273.000.8143,961.13539,569.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918017553/0001437749-18-017553-index.htm
2019-04-01Stefan C LinnChief Operating OfficerBuy20,901.0059,066.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919006476/0001437749-19-006476-index.htm
2019-02-01RICHARD A SANDBERGDirectorSell3,000.0014.2542,750.906,000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774919001701/0001437749-19-001701-index.htm
2020-03-11Matthew T E McLaughlinChief Financial OfficerBuy34,795.0061,407.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920005160/0001437749-20-005160-index.htm
2018-11-01RICHARD A SANDBERGDirectorSell3,000.0015.5046,500.009,000.00https://www.sec.gov/Archives/edgar/data/1586049/000143774918019297/0001437749-18-019297-index.htm
2020-03-11Stefan C LinnChief Operating OfficerBuy37,235.0096,301.00https://www.sec.gov/Archives/edgar/data/1586049/000143774920005158/0001437749-20-005158-index.htm